metoprolol has been researched along with Blindness in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senthilkumaran, S | 1 |
| Balamurgan, N | 1 |
| Sweni, S | 1 |
| Thirumalaikolundusubramanian, P | 1 |
1 other study available for metoprolol and Blindness
| Article | Year |
|---|---|
Acute episode of reversible blindness after an overdose of beta blockers and calcium channel antagonist.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Blindness; Calcium Channel Blockers; Drug Overdose; F | 2011 |